Characterization of putative cis‐regulatory elements that control the transcriptional activity of the human Oct4 promoter

Abstract

Octamer-binding transcription factor-4 (Oct4), a member of the POU domain transcription factors, is crucial for both early embryonic development and the maintenance of stem cell pluripotency. The human Oct4 (hOct4) 5' upstream sequence contains four conserved regions (CR1, 2, 3, 4) that are homologous in the murine. In this study, we constructed a series of deletion mutants of the hOct4 5' upstream region and identified cis-regulatory elements that may be important determinants for the transcriptional activity of the hOct4 promoter. Our studies showed that CR2, 3, and 4 each acted as positive cis-regulatory elements in hOct4 promoter activity. We also newly identified a putative negative cis-acting element located between CR1 and CR2. In addition, the sequence -380/-1 at CR1 that contains a GC box was sufficient to provide the minimal promoter activity. Site-directed mutagenesis and electrophoretic mobility shift assays revealed the GC box located in the -380/-1 region may play a critical role in controlling the transcriptional activity of hOct4 by the direct binding of Sp1 or Sp3 transcription factors to the GC box. An overexpression study showed that Sp1 and Sp3 positively and negatively regulate hOct4 promoter activity. Thus, the hOct4 promoter upstream region contains multiple regulatory elements, one of which, the GC box, may be an important cis-regulatory element that regulates the transcription of the hOct4 promoter by the binding of Sp family transcription factors.

Impact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women

“…It is fascinating that the promoters for two of the key stem cell genes, Oct4 and Nanog, have response elements in their promoters for STAT-1 and STAT-3 which are commonly produced as a result of cytokine signalling, particularly by gp-130 cytokines such as IL-6 and leukaemia inhibitory factor 85 86. Furthermore, there is a three-way cross-talk between stem cell and metabolic-immune genes including STAT-3 and PPARγ 87.…”

Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression

“…Moreover, they reported that treatment of E2 increased transcriptional activity of Sp1, Sp3 transcription factors against GC- rich Sp1, Sp3 site in IL-1α promoter region. Given that Sp sites are also present in OCT4 promoter region [43], it is reasonable to speculate that estrogen might affect OCT4 gene transcription directly, or indirectly.…”

Growth and Differentiation Factor 3 Is Transcriptionally Regulated by OCT4 in Human Embryonic Carcinoma Cells

“…Reporter assays were performed, as described in previous reports. 34,35) Western Blot Analysis NCCIT cells were treated with RA for different amounts of time (0, 2, 4, 6, 8, 10 d) and harvested, or transfected with OCT4-targeting shRNA or the Flag-tagged OCT4 expression vector using the ViaFect transfection reagent (Promega) and harvested 48 h later. Western blotting was performed as previously described 36,37) with a minor modification.…”